ARCHIVES

Alimta Reduces Risk Of Progression In Patients Aged 70 Years or Older

This article is from The Cancer Letter archive.

Vol. 34 No. 10 | October 28, 2011

Download PDF Visit The Full Archive

Related Articles

CMS To Begin National Coverage Analysis Of Provenge

July 2, 2010

Memorial Sloan Kettering Seizes Top Cancer Hospital Prize From MD Anderson In U.S. News & World Report Ranking

July 18, 2014

HHS Names Crawford FDA Deputy Commissioner; Williams Appointed Deputy For Oncology Division.

March 1, 2002

NIH “Just In Time” Procedure Expanded For Two Awards

April 12, 1996

DCBDC Board Ok’s New Initiative For Training

November 16, 1990

NCI Advisors Approve $160-Million Network For Biomarker Discovery, Validation

March 13, 2009